Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.53 AUD | +0.95% | 0.00% | -20.30% |
Apr. 19 | INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test | MT |
Apr. 15 | Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares | MT |
Chart calendar INOVIQ Ltd
Upcoming events on INOVIQ Ltd
Past events on INOVIQ Ltd
2024-04-17 09:00 pm | Investor Meeting |
2024-04-11 10:30 pm | ShareCafe Hidden Gems Investor Webinar |
2024-02-22 04:45 pm | Q2 2024 Earnings Release |
2024-01-30 06:32 pm | December 2023 Sales and Revenue Release - Activities Report |
2023-11-27 06:00 pm | Annual General Meeting |
2023-11-15 | Bell Potter Healthcare Conference |
2023-11-07 | Meeting of the Australia and New Zealand Society for Extracellular Vesicles |
2023-10-29 06:30 pm | September 2023 Sales and Revenue Release - Activities Report |
2023-09-19 09:48 pm | ASX Small and Mid Cap Conference |
2023-08-29 07:00 pm | Q4 2023 Earnings Release |
2023-07-27 07:26 pm | June 2023 Sales and Revenue Release - Activities Report |
2023-06-28 09:00 pm | B2M/CA15-3 Test for Breast Cancer Clinical Data Call |
2023-05-19 07:00 pm | International Society for Extracellular Vesicles Meeting - Abstract No:# PF15.04 |
2023-05-19 07:00 pm | International Society for Extracellular Vesicles Meeting - Abstract No:#PF15.03 |
2023-05-19 07:00 pm | International Society for Extracellular Vesicles Meeting - Abstract No:# PF10.10 |
2023-05-18 07:45 pm | International Society for Extracellular Vesicles Meeting - Abstract No:#PT01.02 |
2023-05-18 03:30 pm | International Society for Extracellular Vesicles Meeting - Abstract No:#OT02.5 |
2023-02-23 05:15 pm | Interim 2023 Earnings Release |
2023-01-30 | December 2022 Sales and Revenue Release - Activities Report |
2022-12-05 06:40 pm | MST Access Diagnostics Forum |
Annual results
Fiscal Period | June | 2023 | 2024 |
---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,00 | 1,60 |
EBITDA Million AUD | Released Forecast Spread | 0,00 | -7,20 |
EBIT Million AUD | Released Forecast Spread | 0,00 | -8,50 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 0,00 | -8,50 |
Net income Million AUD | Released Forecast Spread | -8,97 | -8,50 |
EPS AUD | Released Forecast Spread | -0,10 | -0,09 |
Announcement Date | 29/08/23 | - |
Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for INOVIQ Ltd
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IIQ Stock
- Calendar INOVIQ Ltd